Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

Dow:

Nasdaq:

S&P 500:

TXG

$70.1114.03%-11.44

Nachbörslich: 69.85-0.26 -0.37%

10 X Genomics Inc (TXG)

Date: O: H: L: C: Vol:

10 X Genomics Inc Aktie (TXG) Neueste Nachrichten

Butterfly Network, Inc. (BFLY) Reports Q3 Loss, Beats Revenue Estimates - Zacks Investment Research

Single Cell Sequencing Market Forecast to 2035: Services, Technologies, End-users, Applications, and Regions | 15% CAGR Drives Drug Discovery and Precision Medicine Growth - GlobeNewswire Inc.

TXG 10-Q & SEC Filings - Yahoo Finance - Yahoo! Finance Canada

10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research - Zacks Investment Research

ARK and Catherine D. Wood report ownership above 5% in 10x Genomics (TXG). - Stock Titan

Researchers plan to test whether cell-by-cell analysis can find leukemia left after treatment. - Stock Titan

Global Microfluidics Market by Product Type, Application, End User, and Region, 2026-2036 | $48.04 Billion Opportunity Driven by Point-of-Care Diagnostics and Automation - GlobeNewswire Inc.

10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises - Zacks Investment Research

10x genomics director Shehnaaz Suliman sells $464,667 in stock - Investing.com

Form 4 10X Genomics Inc For: 24 September By Investing.com - Investing.com India

10x genomics director Shehnaaz Suliman sells $464,667 in stock By Investing.com - Investing.com Canada

Form 4 10X Genomics Inc For: 24 September By Investing.com - Investing.com UK

10x genomics director Shehnaaz Suliman sells $464,667 in stock By Investing.com - Investing.com UK

Under a trading plan, a 10x Genomics (TXG) director sells 5,723 shares in five transactions. - Stock Titan

At $77.75 to $82.53 a share, 10x Genomics (TXG) CEO made five sales under a trading plan. - Stock Titan

10x Genomics Insider Sold Shares Worth $464,668, According to a Recent SEC Filing - Yahoo Finance

Form 144 10X Genomics For: 22 September By Investing.com - Investing.com UK

Form 144 10X Genomics For: 22 September By Investing.com - Investing.com Canada

5,723 10x Genomics (NASDAQ: TXG) shares set for Rule 144 sale - Stock Titan

Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia

Moderna, 10x Genomics, Oscar Health, and Novavax Shares Are Soaring, What You Need To Know - Yahoo Finance

10x Genomics (TXG) CFO Adam Taich Sells 46,388 Shares - GuruFocus

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com Nigeria

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com

10x Genomics Inc (TXG) Shares Surge 3.3% -- What GF Score of 56 Tells Investors - GuruFocus

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com

10x Genomics (TXG) CFO sells shares under preset trading plan - Stock Titan

Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia

Korea's Lunit announces collaboration with 10x Genomics for AI-enabled pathology analysis of cancer - BioSpectrum Asia

10x Genomics CFO Adam Taich sells USD 2.99 million in common shares - Bitget

10x genomics CFO Adam Taich disposes of $2.99 million in company stock - Investing.com UK

10x Genomics Insider Sold Shares Worth $2,995,470, According to a Recent SEC Filing - Yahoo Finance

10x Genomics to Use Lunit’s AI-Powered Pathology Platform for Oncology Biomarker Discovery - GenomeWeb

AI will pair tissue scans with molecular maps in cancer studies - Stock Titan

10x genomics director Stuelpnagel sells $1.2 million in shares By Investing.com - Investing.com Australia

10x Genomics (NASDAQ: TXG) executive plans multimillion-dollar stock sale - Stock Titan

10x Genomics Insider John R. Stuelpnagel Sells 20,000 Shares Between $60.66 and $62.61 on September 3, 2026 (NASDAQ: TXG) - kalkinemedia.com

10x Genomics stock hits 52-week high at 66.95 USD By Investing.com - Investing.com South Africa

10x Genomics Insider Sold Shares Worth $1,235,072, According to a Recent SEC Filing - Yahoo Finance

Macrogen to offer 10x Genomics spatial biology platform in Asia first - Korea Biomedical Review

10x genomics director Stuelpnagel sells $1.2 million in shares - Investing.com

10x Genomics Inc (TXG) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 56/100 - GuruFocus

10x Genomics (TXG) director offloads 20,000 shares in open-market trades - Stock Titan

T. Rowe Price reports 10%+ holding in 10x Genomics (TXG) - Stock Titan

Stifel reiterates Buy rating on 10X Genomics stock - investing.com

10x Genomics Director Sold Shares Worth Over $1.2M - TradingView

10X Genomics Inc (TXG) Key Financial Ratios – Valuation, Profitability & More - Value Research

10x Genomics (TXG) CEO holds 1,075,249 shares after 100-share gift - Stock Titan

Founder trust at 10x Genomics (NASDAQ: TXG) moves to sell 20,000 shares - Stock Titan

10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead? - finance.yahoo.com

Ähnlich wie TXG

BRKR$57.077.95%

BIO$372.183.18%

BIO.B$379.504.22%

PODD$149.681.85%

GMED$78.055.86%